Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset (Q38378641)
Jump to navigation
Jump to search
scientific article published on 28 March 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset |
scientific article published on 28 March 2017 |
Statements
1 reference
Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset (English)
1 reference
Katsuyuki Kiura
1 reference
Toyoaki Hida
1 reference
Miyako Satouchi
1 reference
Kazuhiko Nakagawa
1 reference
Takashi Seto
1 reference
Shingo Matsumoto
1 reference
Hiroshi Nokihara
1 reference
Haruyasu Murakami
1 reference
Kota Tokushige
1 reference
Ben Hatano
1 reference
Makoto Nishio
1 reference
28 March 2017
1 reference
1 reference
1-7
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference